The Latest Breaking News from FDA

Drug development has become embarrassingly inefficient in the last decade. Reversing the trend represents a big economic opportunity.

The Food and Drug Administration (FDA) has issued almost 1 million electronic certificates to registrants who seek permission to cultivate cannabis following the legalisation of cannabis and hemp on June 9.

Diversified healthcare company Abbott (ABT) has demonstrated significant innovations across its segments, and given its dominant market position, the company’s prospects look bright. The stock could be a solid choice as it is well-positioned to survive short-term market fluctuations. Let’s discuss this in detail….

These ‘nutritional supplement diffusers’ claim to fight ADHD or treat anxiety or depression, but experts remain wary of effects

LOS ANGELES — Mark had been wanting to quit using meth for a while when someone pointed him to the folding table propped up at the skid row site where homeless people stop for showers and laundry.

Gainers United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the company's recent listing on the Nasdaq Capital Market.

It’s not yet two weeks since the Supreme Court overturned Roe v. Wade, and already the ruling is impeding people’s access to drugs — including drugs not being used for abortions.

Washington (AFP) - When Alabama nurse Melissa went to pick up her regular prescription for rheumatoid arthritis last week, she was told the drug was "on hold" while the pharmacist checked she wasn't going to use it to induce an abortion.

The agency is now taking small steps to allow foreign formula manufacturers to import their goods into the U.S.